The Efficacy of Goal Focused, Non-Pharmacological Treatment for Persons With ADHD/ADD.

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Attention-Deficit Hyperactivity Disorder, Unspecified Type
Interventions
BEHAVIORAL

Goal Attainment Scaling

Individual goals will be formulated and measured by Goal Attainment Scaling (GAS). GAS provides a method for quantifying the attainment of individualized goals, typically set in cognitive rehabilitation. Different levels of outcomes for each goal are operationalized in a five-point scale and given a numeric value. For each individual goal, minus two refers to the goal attainment much less than expected, minus one refers to a little less than expected, zero refers to expected outcome, plus one refers to a little bit better than expected and plus two refers to goal attainment much better than expected. The participants can establish as many goals as desired. Outcomes can be summed within different patient goals, as well as across patients to assess overall outcome of treatment outcomes.

Trial Locations (1)

1478

Akershus University Hospital, DPS Nedre Romerike, Postboks 1000, Loerenskog

All Listed Sponsors
collaborator

University of Oslo

OTHER

lead

University Hospital, Akershus

OTHER

NCT04638283 - The Efficacy of Goal Focused, Non-Pharmacological Treatment for Persons With ADHD/ADD. | Biotech Hunter | Biotech Hunter